Shouguang Fukang Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CLOZAPINE, with a corresponding US DMF Number 25182.
Remarkably, this DMF maintains an Active status since its submission on August 03, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 29, 2014, and payment made on September 25, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II